NDAORALTABLET
Approved
Dec 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
Drug data last refreshed 22h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BYSTOLIC (nebivolol hydrochloride) is an oral beta-blocker tablet approved by the FDA in December 2007 for the treatment of hypertension. It lowers blood pressure through multiple mechanisms including decreased heart rate, reduced myocardial contractility, suppression of renin activity, and vasodilation with decreased peripheral vascular resistance. Nebivolol is a selective beta-1 adrenergic blocker with vasodilatory properties, positioning it as a differentiated option within the crowded antihypertensive market.
$0.0BPart D
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
BYSTOLIC's approaching loss of exclusivity creates limited career opportunities; roles would primarily focus on brand defense and transition management rather than growth. Currently, zero positions are linked to this product in the dataset, reflecting its status as a legacy brand with declining commercial importance. Relevant skill sets would include generic competition strategy, formulary management, and cost-containment positioning rather than innovative commercialization.
Company
Worked on BYSTOLIC at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.